China Traditional Chinese Medicine Holdings Co. Limited (HKG:0570)
Hong Kong
· Delayed Price · Currency is HKD 2.170
+0.020 (0.93%)
May 23, 2025, 4:08 PM HKT
HKG:0570 Revenue
In the year 2024, China Traditional Chinese Medicine Holdings Co. had annual revenue of 16.51B CNY, down -8.90%. China Traditional Chinese Medicine Holdings Co. had revenue of 8.12B in the half year ending December 31, 2024, a decrease of -3.20%.
Revenue
16.51B CNY
Revenue Growth
-8.90%
P/S Ratio
0.62
Revenue / Employee
985.48K CNY
Employees
16,753
Market Cap
10.93B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.51B | -1.61B | -8.90% |
| Dec 31, 2023 | 18.12B | 3.82B | 26.69% |
| Dec 31, 2022 | 14.30B | -4.75B | -24.92% |
| Dec 31, 2021 | 19.05B | 4.25B | 28.68% |
| Dec 31, 2020 | 14.81B | 485.22M | 3.39% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| CSPC Pharmaceutical Group | 30.87B |